Food and Drug Administration

Pulmonary-Allergy Drugs Advisory Committee

September 5, 2003

Holiday Inn, Gaithersburg, MD

Meeting Roster

 

Acting Chairman

Polly E. Parsons, M.D.

 

Executive Secretary
Kimberly Littleton Topper, M.S.

                                                            MEMBERS

 

Vernon Chinchilli, Ph.D.

Talmadge E. King, Jr., M.D.      

Peter E. Morris, M.D., FACP, FCCP      

Consumer Representative

Karen Schell, RRT        


 

Voting Special Government Employees

 

Andrea J. Apter, M.D., M.S.C.

Pulmonary, Allergy and

Critical Care Division
829 Gates Building

Hospital of the

University of Pennsylvania
Philadelphia, Pennsylvania 19104

Carroll Cross, M.D.

University of California

Davis Medical Center,

Pulmonary-Critical Medicine

4150 V Street, Suite 3400

Sacramento, California 95817

 

Jesse Joad, M.D.                     
U.C. Davis Medical Center

Department of Pediatrics
2516 Stockton Boulevard

Carolyn M. Kercsmar, M.D.

Rainbow Babies and

Children’s Hospital

11100 Euclid Ave

Dept. of Pediatrics

Cleveland, Ohio 44106

 

 

 

Lee S. Newman, M.D., M.A., F.C.C.P.

National Jewish Medical

and Research Center

Department of Medicine

Division of Environmental and

 Occupational Health Sciences

1400 Jackson Street, Room G212

Denver, Colorado 80206

 

Christina M. Surawicz, M.D

Professor of Medicine

Harborview Medical Center

325 9th Avenue, Box 359773

Seattle, Washington 98104

 

 

Non-Voting Industry Representative

 

William Kennedy

1313 Delaware Avenue

Wilmington, Delaware 19806

 

Food and Drug Administration

Pulmonary-Allergy Drugs Advisory Committee

September 5, 2003

Holiday Inn, Gaithersburg, MD

Meeting Roster

 

 

 

FDA  STAFF

 

 

 

Raymond F. Anthracite, M.D.

Medical Officer

U.S. Food and Drug Administration

Center for Drug Evaluation and Research

Office of Drug Evaluation II

Division of Pulmonary and Allergy Drug Products

 

Badrul Chowdhury, M.D.

Division Director

U.S. Food and Drug Administration

Center for Drug Evaluation and Research

Office of Drug Evaluation II

Division of Pulmonary and Allergy Drug Products

 

James Gebert, Ph.D.

Statistician

U.S. Food and Drug Administration

Center for Drug Evaluation and Research

Office of Biostatistics

Division of Biometrics II

 

Robert Meyer, M.D.

Director

U.S. Food and Drug Administration

Center for Drug Evaluation and Research

Office of Drug Evaluation II

 

Sandra Suarez-Sharp, Ph.D.

Clinical Pharmacologist

U.S. Food and Drug Administration

Center for Drug Evaluation and Research

Office of Pharmaceutical Science

Office of Clinical Pharmacology and Biopharmaceutics

 

Virgil Whitehurst, Ph.D.

Pharmacologist

U.S. Food and Drug Administration

Center for Drug Evaluation and Research

Office of Drug Evaluation II

Division of Pulmonary and Allergy Drug Products